is a rare disorder with an annual incidence of 3.7 cases per 106 individuals [2], possibly slightly increasing in recent years [3]. It is characterised by microvascular platelet clumping resulting in Background: Severe deficiency of von Wille-brand factor-cleaving protease (ADAMTS-13) ac-tivity (<5 % of normal) is specific for classical thrombotic thrombocytopenic purpura (TTP), a disorder presenting with thrombocytopenia, mi-croangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever. A certain, though accord-ing to several case series, variable percentage of pa-tients with clinically diagnosed TTP and most pa-tients with other forms of thrombotic microan-giopathies (TMA) do...
Background Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and m...
Abstract TTP is characterized by microangiopathic hemolytic anemia and thrombocytopenia associated w...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
Thrombotic microangiopathy is featured by microangiopathic haemolytic anaemia, thrombocytopenia and ...
Thrombotic thrombocytopenic purpura (TTP) is characterized by microangiopathic hemolytic anemia and ...
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disorder characterized by single or ...
Thrombotic microangiopathy can be caused by several conditions which are difficult to diagnose from ...
Severe ADAMTS13 deficiency occurs in 13% to 75% of thrombotic microangiopathies (TMA). In this conte...
The congenital or acquired deficiency of the von Willebrand factor (VWF) cleaving protease, ADAMTS-1...
Thrombotic microangiopathies (TMAs) represent a heterogeneous group of entities characterized by the...
Thrombotic microangiopathies (TMA) represent an eclectic group of conditions, which share hemolytic ...
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disease, disease, characterise...
International audienceThe significance of ADAMTS13 deficiency in adult thrombotic microangiopathy (T...
Retrospective studies of patients with thrombotic microangiopathies (TMAs) have shown that a deficie...
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy ...
Background Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and m...
Abstract TTP is characterized by microangiopathic hemolytic anemia and thrombocytopenia associated w...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
Thrombotic microangiopathy is featured by microangiopathic haemolytic anaemia, thrombocytopenia and ...
Thrombotic thrombocytopenic purpura (TTP) is characterized by microangiopathic hemolytic anemia and ...
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disorder characterized by single or ...
Thrombotic microangiopathy can be caused by several conditions which are difficult to diagnose from ...
Severe ADAMTS13 deficiency occurs in 13% to 75% of thrombotic microangiopathies (TMA). In this conte...
The congenital or acquired deficiency of the von Willebrand factor (VWF) cleaving protease, ADAMTS-1...
Thrombotic microangiopathies (TMAs) represent a heterogeneous group of entities characterized by the...
Thrombotic microangiopathies (TMA) represent an eclectic group of conditions, which share hemolytic ...
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disease, disease, characterise...
International audienceThe significance of ADAMTS13 deficiency in adult thrombotic microangiopathy (T...
Retrospective studies of patients with thrombotic microangiopathies (TMAs) have shown that a deficie...
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy ...
Background Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and m...
Abstract TTP is characterized by microangiopathic hemolytic anemia and thrombocytopenia associated w...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...